Avon Protection PLC

Avon Protection PLC

IndustrialsAerospace and Defense
  • Price (GBX)876.00
  • Today's Change-7.50 / -0.85%
  • Shares traded8.60k
  • 1 Year change-32.62%
  • Beta0.3725
Data delayed at least 20 minutes, as of Mar 20 2023 16:35 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Avon Protection PLC is a United Kingdom-based technology company. The Company designs and produces life critical personal protection solutions for the militaries and first responders, with a portfolio that includes chemical, biological, radiological, nuclear (CBRN), respiratory and head protection products. Its brands include Avon Protection and Team Wendy. Avon Protection is a provider of life critical personal protection systems. Team Wendy is a supplier of helmets and helmet liner and retention systems. Its product portfolio includes respiratory protection and head protection. The Company's respiratory protection product portfolio includes respirators, powered and supplied air systems, filters, spares and accessories, as well as underwater systems. Its head protection portfolio is focused on bump protection helmets, helmet liner and retention systems. Its subsidiaries include Avon Polymer Products Limited, Avon Protection Holdings Limited and Avon Rubber Pension Trust Limited.

  • Revenue in GBP (TTM)223.33m
  • Net income in GBP-4.60m
  • Incorporated1890
  • Employees1.01k
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
ADDvise Group AB (publ)74.41m6.34m152.93m334.0023.903.9317.942.060.44940.44945.362.730.62644.434.31--5.343.186.584.2060.6749.368.524.,791.19------
Tristel Plc34.94m1.24m156.38m199.00126.145.5437.714.480.02620.07230.73980.59710.92661.786.22175,577.903.299.213.6710.7478.5779.793.5510.783.6329.250.16599.2614.278.95-41.88-22.973.6810.20
Prim SA172.80m7.40m156.72m673.0021.181.4910.630.90690.49580.495811.597.031.091.654.91--4.667.346.259.5446.4240.784.287.281.35--0.155457.7017.0510.22-51.52-9.48---17.56
Carmat SA1.96m-53.89m170.65m171.00--11.54--87.27-3.57-3.570.12590.7450.02662.410.516613,950.00-73.19-74.68-85.10-90.22-1,569.76---2,755.78-9,530.824.86-16.090.7856-------67.39--9.97--
SDI Group PLC56.72m8.21m175.90m354.0021.554.2615.063.100.07870.07870.54330.39780.80492.215.86160,228.8011.6510.5715.1213.6363.0064.9414.4813.010.785922.300.3910.0041.5735.8160.2255.5616.50--
Meditera Tibbi Malzeme Sanayi ve34.80m12.82m178.18m721.0013.894.6613.375.122.502.506.777.440.88643.895.621,117,946.0032.66--38.44--46.08--36.85--3.88--0.0547--114.41--77.13------
Bactiguard Holding AB19.82m-4.13m195.17m210.00--5.68--9.85-1.51-1.517.2314.150.3063.155.62---6.38-4.29-7.00-4.8250.0452.87-20.86-15.243.13-13.290.325--41.5810.5310.03--11.87--
Bastide Le Confort Medical SA410.27m12.65m218.64m3.38k17.342.923.450.53291.961.8563.5111.620.77945.187.66138,755.602.512.433.463.4149.5148.263.222.910.78963.110.8287--5.4616.517.3621.6314.53--
IVF Hartmann Holding AG133.60m9.95m243.71m316.0024.481.9115.791.824.684.6862.7759.860.85232.648.81476,737.306.357.527.779.1553.1853.447.458.323.2439.340.003550.344.572.5380.79-6.86-5.250.00
Detection Technology Oyj86.36m4.48m250.38m469.0055.873.9334.272.900.34910.34916.734.961.072.272.95210,192.505.5712.356.9916.2245.9048.165.1910.403.191,486.720.041247.459.762.07-45.04-19.52-2.35-10.59
Avon Protection PLC223.33m-4.60m265.84m1.01k--1.5819.981.19-0.147-0.20117.375.570.72833.037.22221,775.40-1.500.8486-1.721.0528.7635.31-
PharmaSGP Holding SE72.82m9.64m306.98m73.0031.8512.7117.304.220.91690.91696.932.300.65291.737.561,259,470.008.64--17.36--88.70--13.24--
Lumibird SA149.88m8.78m308.63m992.0035.261.8815.272.060.44470.44477.888.330.51121.175.10187,
BICO Group AB175.12m-65.13m312.20m1.16k--0.5901--1.78-12.73-12.7334.4697.950.22450.92462.851,932,269.00-8.38---9.17--81.74---37.31--2.03--0.2109--78.12---265.95------
Medistim ASA37.86m8.77m342.96m116.0038.9712.0632.469.066.246.2426.9220.
CellaVision AB49.99m9.25m369.29m234.0039.917.3629.817.394.964.9626.8126.900.74471.566.82--13.7816.7916.3320.2368.5669.9718.5120.821.7616.090.137729.7613.0515.63-5.5911.1618.938.45
Data as of Mar 20 2023. Currency figures normalised to Avon Protection PLC's reporting currency: UK Pound GBX

Institutional shareholders

58.56%Per cent of shares held by top holders
HolderShares% Held
Alantra EQMC Asset Management SGIIC SAas of 29 Nov 20223.58m11.84%
Van Lanschot Kempen Investment Management NVas of 07 Feb 20233.03m10.00%
Ancora Alternatives LLCas of 15 Dec 20221.53m5.07%
Polar Capital LLPas of 18 Dec 20191.52m5.02%
Chelverton Asset Management Ltd.as of 08 Feb 20221.50m4.96%
Martin Currie Investment Management Ltd.as of 28 Mar 20221.49m4.91%
Janus Henderson Investors UK Ltd.as of 30 Oct 20191.41m4.66%
BlackRock Investment Management (UK) Ltd.as of 12 Nov 20211.36m4.51%
Royal London Asset Management Ltd.as of 02 Feb 20231.25m4.13%
Schroder Investment Management Ltd.as of 30 Sep 20211.05m3.48%
More ▼
Data from 30 Jun 2022 - 10 Mar 2023Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.